254 related articles for article (PubMed ID: 37515699)
81. D-Limonene: an emerging antineoplastic agent.
Kapoor S
Hum Exp Toxicol; 2013 Nov; 32(11):1228. PubMed ID: 23716733
[No Abstract] [Full Text] [Related]
82. Terpenoids as anti-colon cancer agents - A comprehensive review on its mechanistic perspectives.
Sharma SH; Thulasingam S; Nagarajan S
Eur J Pharmacol; 2017 Jan; 795():169-178. PubMed ID: 27940056
[TBL] [Abstract][Full Text] [Related]
83. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
84. Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma.
Benedicto A; Hernandez-Unzueta I; Sanz E; Márquez J
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669949
[TBL] [Abstract][Full Text] [Related]
85. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets.
Grossman D; Altieri DC
Cancer Metastasis Rev; 2001; 20(1-2):3-11. PubMed ID: 11831644
[TBL] [Abstract][Full Text] [Related]
86. Determination of Some Isoquinoline Alkaloids in Extracts Obtained from Selected Plants of the Ranunculaceae, Papaveraceae and Fumarioideae Families by Liquid Chromatography and In Vitro and In Vivo Investigations of Their Cytotoxic Activity.
Misiurek J; Plech T; Kaproń B; Makuch-Kocka A; Szultka-Młyńska M; Buszewski B; Petruczynik A
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110737
[TBL] [Abstract][Full Text] [Related]
87. The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review).
Cho M; So I; Chun JN; Jeon JH
Int J Oncol; 2016 May; 48(5):1772-82. PubMed ID: 26983575
[TBL] [Abstract][Full Text] [Related]
88. Downregulation of tumor growth and invasion by redox-active nanoparticles.
Alili L; Sack M; von Montfort C; Giri S; Das S; Carroll KS; Zanger K; Seal S; Brenneisen P
Antioxid Redox Signal; 2013 Sep; 19(8):765-78. PubMed ID: 23198807
[TBL] [Abstract][Full Text] [Related]
89. Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells.
Calcabrini A; Stringaro A; Toccacieli L; Meschini S; Marra M; Colone M; Salvatore G; Mondello F; Arancia G; Molinari A
J Invest Dermatol; 2004 Feb; 122(2):349-60. PubMed ID: 15009716
[TBL] [Abstract][Full Text] [Related]
90. Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis.
Ye Z; Liang Z; Mi Q; Guo Y
J BUON; 2020; 25(1):280-285. PubMed ID: 32277643
[TBL] [Abstract][Full Text] [Related]
91. X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma.
Tian F; Lee SW
J Invest Dermatol; 2010 Sep; 130(9):2169-72. PubMed ID: 20711206
[TBL] [Abstract][Full Text] [Related]
92. The anticancer activity of visnagin, isolated from Ammi visnaga L., against the human malignant melanoma cell lines, HT 144.
Aydoğmuş-Öztürk F; Jahan H; Beyazit N; Günaydın K; Choudhary MI
Mol Biol Rep; 2019 Apr; 46(2):1709-1714. PubMed ID: 30694454
[TBL] [Abstract][Full Text] [Related]
93. Skin repair properties of d-Limonene and perillyl alcohol in murine models.
d'Alessio PA; Mirshahi M; Bisson JF; Bene MC
Antiinflamm Antiallergy Agents Med Chem; 2014 Mar; 13(1):29-35. PubMed ID: 24160248
[TBL] [Abstract][Full Text] [Related]
94. Potential role of Marine Bioactive Compounds in cancer signaling pathways: A review.
Manoharan S; Perumal E
Eur J Pharmacol; 2022 Dec; 936():175330. PubMed ID: 36265609
[TBL] [Abstract][Full Text] [Related]
95. In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenografts.
Agrawal V; Woo JH; Mauldin JP; Stone EM; Meininger CJ; Jo C; Kleypas K; Frenkel EP; Frankel AE
Melanoma Res; 2014 Dec; 24(6):556-67. PubMed ID: 25304236
[TBL] [Abstract][Full Text] [Related]
96. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
[TBL] [Abstract][Full Text] [Related]
97. Next-Gen Therapeutics for Skin Cancer: Nutraceuticals.
Sreedhar A; Li J; Zhao Y
Nutr Cancer; 2018 Jul; 70(5):697-709. PubMed ID: 29764209
[TBL] [Abstract][Full Text] [Related]
98. Exploring the Therapeutic Potential of Terpenoids for Depression and Anxiety.
Azimi A
Chem Biodivers; 2024 Jun; ():e202400788. PubMed ID: 38934531
[TBL] [Abstract][Full Text] [Related]
99. Morphological aspects and therapeutic options in melanoma: a narrative review of the past decade.
Tinca AC; Raicea A; Szőke AR; Cocuz IG; Şincu MC; Niculescu R; Sabău AH; Popelea MC; Fruntelată RF; Cotoi OS
Rom J Morphol Embryol; 2023; 64(2):135-141. PubMed ID: 37518869
[TBL] [Abstract][Full Text] [Related]
100. Green nanoarchitectonics of carbon quantum dots from Cinchona Pubescens Vahl as targeted and controlled drug cancer nanocarrier.
González-Reyna MA; Molina GA; Juarez-Moreno K; Rodríguez-Torres A; Esparza R; Estevez M
Biomater Adv; 2023 Oct; 153():213561. PubMed ID: 37515841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
